Hims & Hers Health Inc (NYSE:HIMS) reported financial results for the fourth quarter after the market close on Monday. Here’s a look at the key details from the print.
- Hims & Hers Health stock is showing weakness. What’s pulling HIMS shares down?
Hims & Hers Beats EPS Estimates, Misses Revenue Mark
Hims & Hers Health reported fourth-quarter revenue of $617.82 million, missing analyst estimates of $619.22 million. The company reported fourth-quarter earnings of eight cents per share, beating estimates of three cents per share, according to Benzinga Pro.
Total revenue was up 28% on a year-over-year basis as subscribers grew to over 2.5 million in the quarter, up 13% in 2025. Gross margin came in at 72% in the fourth quarter, down from 77% in the comparable quarter in 2024.
“More than 2.5 million subscribers now rely on us for a health care experience that is both accessible and deeply personal — and we believe we’re well on our way to becoming the global leader in consumer health,” said Andrew Dudum, co-founder and CEO of Hims & Hers Health.
The company reported operating cash flow of $61.3 million and negative free cash flow of $2.6 million in the quarter. Hims & Hers ended the period with $228.62 million in cash and cash equivalents.
What’s Next For HIMS?
Hims & Hers Health expects first-quarter revenue of $600 million to $625 million versus estimates of $653.12 million. The company also guided for full-year 2026 revenue of $2.7 billion to $2.9 billion versus estimates of $2.74 billion.
“With a strong balance sheet and robust operating cash flow from tenured specialties in our domestic operations, we have the flexibility to invest in scaling new specialties, advancing our technology and infrastructure, and expanding internationally, all supporting our path toward our 2030 targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA,” said Yemi Okupe, CFO of Hims & Hers Health.
Hims & Hers executives will further discuss the quarter on an earnings call with investors and analysts at 5 p.m. ET.
HIMS Stock Volatile After The Bell
HIMS Price Action: Hims & Hers Health shares initially traded lower after the report. The stock has been volatile in after-hours Monday, trading down 0.64% at $15.41 at publication time, according to Benzinga Pro.
Image: Shutterstock.com
Recent Comments